JUN 30, 2020 6:21 AM PDT

PAR glycohydrolase inhibitors to enhance treatment for gliomas

New hope for glioma patients comes in the form of a novel strategy to target tumors, the results of which are published in Cancer Discovery, a journal of the American Association for Cancer Research. The research was spearheaded by investigators at Massachusetts General Hospital who hope to inform mechanisms that will improve treatment options for the disease. 

While patients with glioma brain tumors can receive surgery, radiation, and chemotherapy, these treatment options do not always offer a cure to the disease. However, past work led by Mass General's Daniel Cahill, MD, Ph.D., Hiroaki Wakimoto, MD, Ph.D., and Julie Miller, MD, Ph.D., demonstrated how mutations in the isocitrate dehydrogenase (IDH) genes have a metabolic Achilles heel. What they found is that mutant IDH genes are particularly susceptible to treatments that lower levels of NAD+, an important metabolic molecule. 

So the researchers combined this knowledge with another key piece of information: chemotherapy activates an enzyme that stimulates NAD+ molecules to unite to produce poly(ADP-ribose), or PAR, which is a key DNA damage signal. And it only does this in IDH mutant glioma cells, not healthy cells. 

Knowing this, the researchers figured this provided the perfect opportunity to target IDH mutant glioma cells by maintaining high PAR levels and low NAD+ levels through chemotherapy.

Gliomas account for about 25% of childhood cancers. Photo: Pixabay

"We found that maximum effectiveness was achieved by combining two agents: temozolomide, the chemotherapy most commonly used to treat patients with IDH mutant gliomas, with a drug that blocks PAR breakdown, known as a PAR glycohydrolase inhibitor," said Dr. Cahill, 

Dr. Wakimoto continues, explaining: "We showed, for the first time, that PAR glycohydrolase inhibitors can be used to enhance the effectiveness of chemotherapy in tumors with metabolic weaknesses in the NAD+ pathway.”

Dr. Miller concludes that their findings have real-life implications for glioma patients. "The long-term significance is that, based on our findings, they could be tested in individuals with IDH mutant gliomas, with a goal of hopefully improving outcomes in these patients," she said.

Sources: Cancer Discovery, Eureka Alert

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
JUN 28, 2020
Cell & Molecular Biology
Insight Into How Dietary Changes Could Affect Cancer Therapies
JUN 28, 2020
Insight Into How Dietary Changes Could Affect Cancer Therapies
Researchers are investigating the complex relationship between cancer, diet, and metabolism in cells, and are attempting ...
JUL 04, 2020
Cancer
New mechanism that supports the progression and relapse cancer discovered
JUL 04, 2020
New mechanism that supports the progression and relapse cancer discovered
Researchers have found a mechanism of a key protein that supports the progression and relapse of cancer. This discovery ...
JUL 12, 2020
Cell & Molecular Biology
Lung Cancer is Different in Non-Smokers
JUL 12, 2020
Lung Cancer is Different in Non-Smokers
Not everyone that gets lung cancer is a current or former smoker, and researchers have now found that lung cancer is dif ...
AUG 03, 2020
Cancer
Improving Diagnostics in Breast Cancer
AUG 03, 2020
Improving Diagnostics in Breast Cancer
Diagnostics is one of the essential tools in a physician’s toolkit. A good diagnostic test can identify whether a ...
AUG 07, 2020
Cancer
Immune-Related Genes as Prognostic Biomarkers
AUG 07, 2020
Immune-Related Genes as Prognostic Biomarkers
Cancer is one of the most persistent and hardy diseases. Cancers often develop the ability to suppress the immune system ...
AUG 06, 2020
Clinical & Molecular DX
Gut Feeling: Spotting the Early Signs of Gastric Cancer
AUG 06, 2020
Gut Feeling: Spotting the Early Signs of Gastric Cancer
In a study published in Science Advances, scientists propose a new method for diagnosing gastric cancer, the third leadi ...
Loading Comments...